Search research articles
Contact Us
Filters
Showing results (911-920 of 1,708) with videos related to
Page
of 171
Sort By:
Circulation. Cardiovascular Quality and Outcomes
|
September 6, 2012
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction
Keith A Somma, Deepak L Bhatt, Gregg C Fonarow, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 21, 2012
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction
Sumeet Subherwal, Deepak L Bhatt, Shuang Li, et al.
Research and Practice in Thrombosis and Haemostasis
|
November 9, 2022
Case-fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis
Tobias Tritschler, Anuj Patel, Noémie Kraaijpoel, et al.
NPJ Digital Medicine
|
August 24, 2024
Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population
Joy Jiang, Ha My Thi Vy, Alexander Charney, et al.
European Heart Journal
|
February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
Jonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
Journal of the American Heart Association
|
February 13, 2017
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
Lauren G Gilstrap, Gregg C Fonarow, Akshay S Desai, et al.
American Heart Journal
|
June 20, 2017
Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis
Eldrin F Lewis, Rui Wang, Naresh Punjabi, et al.
Circulation
|
June 3, 2010
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Peter B Berger, Deepak L Bhatt, Valentin Fuster, et al.
Circulation. Heart Failure
|
February 13, 2016
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry
Prateeti Khazanie, Li Liang, Lesley H Curtis, et al.
American Heart Journal
|
February 26, 2022
Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial
Sarah C Couch, Robert N Helsley, Francesca U Siegel, et al.
Page
of 171
Search research articles
Search
Showing results (911-920 of 1,708) with videos related to
Sort By:
Page
of 171
Circulation. Cardiovascular Quality and Outcomes
|
September 6, 2012
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction
Keith A Somma, Deepak L Bhatt, Gregg C Fonarow, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 21, 2012
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction
Sumeet Subherwal, Deepak L Bhatt, Shuang Li, et al.
Research and Practice in Thrombosis and Haemostasis
|
November 9, 2022
Case-fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta-analysis
Tobias Tritschler, Anuj Patel, Noémie Kraaijpoel, et al.
NPJ Digital Medicine
|
August 24, 2024
Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population
Joy Jiang, Ha My Thi Vy, Alexander Charney, et al.
European Heart Journal
|
February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
Jonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
Journal of the American Heart Association
|
February 13, 2017
Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction
Lauren G Gilstrap, Gregg C Fonarow, Akshay S Desai, et al.
American Heart Journal
|
June 20, 2017
Impact of continuous positive airway pressure and oxygen on health status in patients with coronary heart disease, cardiovascular risk factors, and obstructive sleep apnea: A Heart Biomarker Evaluation in Apnea Treatment (HEARTBEAT) analysis
Eldrin F Lewis, Rui Wang, Naresh Punjabi, et al.
Circulation
|
June 3, 2010
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Peter B Berger, Deepak L Bhatt, Valentin Fuster, et al.
Circulation. Heart Failure
|
February 13, 2016
Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry
Prateeti Khazanie, Li Liang, Lesley H Curtis, et al.
American Heart Journal
|
February 26, 2022
Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trial
Sarah C Couch, Robert N Helsley, Francesca U Siegel, et al.
Page
of 171